focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.00
Ask: 5.50
Change: -0.25 (-5.00%)
Spread: 1.50 (37.50%)
Open: 5.00
High: 5.00
Low: 4.75
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of Options

3 Jul 2009 07:00

RNS Number : 0356V
Braveheart Investment Group plc
03 July 2009
 



3 July 2009

Braveheart Investment Group plc

('Braveheart' or 'the Group')

Award of Options

Braveheart (AIM: BRH), the technology commercialisation and investment management company, announces that the directors and staff named below have been awarded the following new options over the Group's Ordinary Shares:

Employment Based

Performance Based

Total

Directors:

Geoffrey Thomson

42,753

69,231

111,984

Carolyn Smith

31,669

41,538

73,207

Colin Grant

30,160

41,538

71,698

Staff

187,244

140,193

327,437

Total

291,826

292,500

584,326

The exercise price for the new options is 29.5p. The employment options will become exercisable on the third anniversary of grant and the performance options will become exercisable on the first anniversary following achievement of the performance condition.

The resulting aggregate options held are as below:

Employment Based

Performance Based

Total

Directors:

Garry Watson

-

33,454

33,454

Edward Cunningham

-

13,360

13,360

Geoffrey Thomson

108,164

153,568

261,732

Carolyn Smith

79,051

92,140

171,191

Colin Grant

59,062

76,636

135,698

Staff

308,468

207,598

516,066

Total

554,745

576,756

1,131,501

For further information please visit www.braveheart-ventures.co.uk or contact:

Braveheart Investment Group

Tavistock Communications

Geoffrey Thomson, Chief Executive

Simon Hudson / James Midmer

Tel: 01738 587555

Tel: 020 7920 3150

gthomson@braveheart-ventures.co.uk

shudson@tavistock.co.uk 

Seymour Pierce Limited 

(Nominated Advisers to Braveheart)

Richard Feigen/Catherine Leftley

Tel: 020 7107 8000

Notes to Editors

Braveheart Investment Group is a technology commercialisation and investment management company based in PerthScotland. Since its formation in 1997 it has made the transition from start-up angel syndicate to fully listed company. Braveheart's shares listed on AIM in March 2007.

Investments are made in young, emerging, unlisted companies where there is potential for significant growth through successful commercialisation of IP and Braveheart enjoys close relationships with several universities to identify emerging technologies. Investments are predominantly technology-focused; however the Group also maintains limited exposure to more traditional businesses.

Braveheart's diverse portfolio currently comprises over 30 companies and it has completed over 80 deals in its eleven year history, including six IPOs, three trade sales and eight write-offs and has an exit IRR of 33%.

At the 2008 Ernst & Young Entrepreneur of The Year Awards (Scotland) Braveheart CEO Geoffrey Thomson was given a special award recognising his contribution and support of emerging technology businesses in Scotland over the past decade.

On 8 June 2009 the Group announced the acquisition of Inkopo Limited. This acquisition, based principally on an earn-out consideration, gives the Group an established presence in Yorkshire, an additional revenue stream and further complementary income from investment facilitation and management activities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDRSDGGGCD
Date   Source Headline
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 20208:52 amRNSExercise of Warrants and Issue of Equity
3rd Nov 202011:06 amRNSSecond Price Monitoring Extn
3rd Nov 202011:00 amRNSPrice Monitoring Extension
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
29th Oct 20204:40 pmRNSSecond Price Monitoring Extn
29th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20207:00 amRNSIssue of shares to certain directors and TVR
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:00 pmRNSPrice Monitoring Extension
23rd Oct 20207:00 amRNSUpdate on Pharm2Farm’s COVID-19 mask project
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202012:42 pmRNSFurther re. Conditional Sale of Pharm2Farm holding
19th Oct 202012:35 pmRNSPublication of Circular and Notice of GM
16th Oct 20207:00 amRNSFurther update re Paraytec Limited
8th Oct 20204:09 pmRNSUpdate on Pharm2Farm
5th Oct 202011:20 amRNSFurther update re Paraytec Limited
29th Sep 20204:40 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
24th Sep 20207:00 amRNSUpdate on Phasefocus Holdings Limited
18th Sep 20207:00 amRNSUpdate on the Pharm2Farm anti-viral mask project
8th Sep 202012:18 pmRNSResult of AGM
3rd Sep 20207:00 amRNSFurther re Paraytec Limited
28th Aug 20205:00 pmRNSTotal Voting Rights
21st Aug 20205:09 pmRNSConditional Sale of Pharm 2 Farm Limited holding
20th Aug 20201:04 pmRNSHolding(s) in Company
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20207:00 amRNSFurther re Paraytec Limited
4th Aug 20207:00 amRNSFinal Results
23rd Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20207:18 amRNSParticipation in RMS placing
7th Jul 20207:00 amRNSFurther re Paraytec Limited
1st Jul 20202:31 pmRNSHolding(s) in Company
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20203:00 pmRNSAcquisition of 18.1% interest in RMS
19th Jun 20202:29 pmRNSOperational Update
9th Jun 20207:00 amRNSFurther re Paraytec Limited
8th Jun 20207:00 amRNSHolding(s) in Company
5th Jun 202012:44 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSAcquisition of Additional PhaseFocus Shares
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.